In Cell Culture you eventually passage the dish: wipe everything and start over, in exchange for a permanent bonus. That is a real laboratory procedure with a real name, done for real reasons — and the game gets one important thing exactly backwards.
Growing cells in a dish is less like farming and more like managing a small city with a housing shortage.
Cells stuck to the bottom of a flask divide and spread outward until they cover the surface. When they have, the culture is confluent — a single continuous sheet with no bare plastic left. At that point growth slows and stops, for two reasons that both matter.
The first is chemistry. A dense population exhausts the nutrients in the liquid medium and fills it with their own waste products. The second is more interesting: normal cells stop dividing when they are surrounded by other cells. Touching neighbours on all sides is itself the signal to stop. This is called contact inhibition, and it is the same mechanism that stops your skin from growing indefinitely once a wound has closed.
So the culture stalls — not because anything went wrong, but because it worked.
Passaging (also called subculturing, or just "splitting") solves this by moving a fraction of the population into a new home. In outline:
Now there is bare surface again, plenty of nutrients, and the cells resume dividing. Repeat every few days, indefinitely — or at least, that is the hope.
For the first half of the twentieth century, the accepted view was that cells in culture were immortal — that with adequate food and care a population could be maintained forever, and any failure was a failure of technique. That belief rested largely on one long-running and famously irreproducible experiment.
In the early 1960s, Leonard Hayflick showed it was wrong. Normal human cells divide a limited number of times — for typical human fetal cells, somewhere in the range of forty to sixty divisions — and then stop permanently. They do not die. They sit there, metabolically active, refusing to divide again. This state is called replicative senescence, and the ceiling is now known as the Hayflick limit.
Crucially, it is a count, not a clock. Cells frozen partway through and revived years later resume from where they left off. Something inside is tallying divisions.
The answer turned out to be at the ends of the chromosomes.
Chromosome ends carry telomeres: long stretches of repeated, non-coding sequence that protect the real genes behind them. They exist because of an awkward mechanical fact — the machinery that copies DNA cannot quite finish the very end of a strand. Every replication leaves the tip slightly shorter.
Telomeres are the buffer that absorbs this loss. They are meaningless sequence, so shortening them costs nothing at first. But the buffer is finite. After enough divisions the telomeres become critically short, the cell registers this as a form of damage, and the checkpoint machinery shuts division down for good.
It is an elegant solution to a problem that has no clean fix: since you cannot copy the end of a strand, put something expendable there and count how many times you have used it.
Some cells must divide indefinitely. Stem cells and the cells that produce eggs and sperm cannot afford a ceiling, and they get around it with an enzyme called telomerase, which rebuilds telomeres and resets the counter.
Most adult body cells switch telomerase off. That is a deliberate safety feature: a cell that can divide without limit is exactly what a tumour requires. And so the vast majority of cancers reactivate telomerase or find another way to maintain their telomeres. The Hayflick limit is, among other things, an anti-cancer mechanism — and one of the standard steps in becoming a cancer is defeating it.
This is why some laboratory cell lines can be passaged forever. They are not better-behaved normal cells; they are cells that have escaped the ceiling, usually because they came from a tumour or were deliberately engineered to.
The most consequential immortal line in biology began in 1951, when a sample was taken from a cervical tumour of a woman named Henrietta Lacks during treatment at Johns Hopkins. She died of that cancer within months. She was never told the sample had been taken, and never consented to it.
Her cells did what no human cells had reliably done in a laboratory before: they kept growing. They grew robustly, they grew fast, and they did not stop. Named HeLa from the first letters of her name, they became the workhorse of twentieth-century cell biology — used in developing the polio vaccine, in cancer and virus research, and in an enormous share of the literature since.
Her family did not learn of any of this for more than twenty years, and did not share in the commercial value derived from the cells. The case is now a standard reference point in discussions of consent and tissue ownership, and it changed how research institutions handle both.
In Cell Culture, passaging makes you permanently stronger. Each reset banks culture medium, and every point of it raises output forever.
Reality runs the other way. Passaging a normal culture spends something irreplaceable: divisions from a finite budget, and telomere length that will not grow back. High-passage cells are typically less reliable, not more. A real dish does not get better each time you split it — it gets closer to the end.
And yet the mechanic is not simply wrong, because there is one class of cell for which repeated passaging genuinely does compound without cost: the immortalised lines. Cells that have already escaped the limit really can be split forever, and every split really does yield more material to work with.
So the game's petri dish behaves like HeLa rather than like a normal primary culture. Which, given that it also lets you grow neurons and heart muscle in the same dish and sells you CRISPR as a global upgrade, is a liberty well within its budget.
Written for a general audience; details are simplified deliberately. Related reading: The Eight Cell Types in Cell Culture, Explained. Corrections are welcome via the contact page.